Number of Shares
244,578.00
Current Holdings Value*
$14.47 Mil
% of Portfolio
3.36%
Total Estimate Gain
$5.25 Mil
% of Total Estimate Gain
32.27%

Neuberger Berman Small Cap Growth Fund's Halozyme Therapeutics Inc Holding Summary

As of 2025-02-28, NEUBERGER BERMAN EQUITY FUNDS held 244,578.00 shares of Halozyme Therapeutics Inc(HALO), totaling $14.47 Mil. This investment constitutes 3.36% of their stock portfolio, and NEUBERGER BERMAN EQUITY FUNDS now holds 0.2% of the outstanding Halozyme Therapeutics Inc(HALO) stock.

The initial trade took place in 2020Q2. And since then Neuberger Berman Small Cap Growth Fund has made 11 purchases of HALO, at an average price of $39.31, for a total of 413,844.00 shares. In addition, there have been 4 sales at an average price of $43.61 for 169,266.00 shares. Based on historical transaction data and HALO's current price of $57.81, Neuberger Berman Small Cap Growth Fund's estimated gain on his HALO holdings is $5.25 Mil, reflecting a 32.27% gain to date.

Neuberger Berman Small Cap Growth Fund HALO ($57.81) Holding Chart

Neuberger Berman Small Cap Growth Fund HALO ($57.81) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1